Cure of apparent mineralocorticoid excess by kidney transplantation

被引：42

作者：

Palermo, M ^{[1
]}

Cossu, M

Shackleton, CHL

机构：

[1] Univ Sassari, I-07100 Sassari, Italy

[2] SS Annunziata Hosp, Sassari, Italy

[3] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1998年 / 339卷 / 24期

关键词：

D O I：

10.1056/NEJM199812103392414

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1787 / 1788

页数：2

共 4 条

[1] Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess [J].

Li, A ;

Tedde, R ;

Krozowski, ZS ;

Pala, A ;

Li, KXZ ;

Shackleton, CHL ;

Mantero, F ;

Palermo, M ;

Stewart, PM .

AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (02) :370-379

[2] Apparent mineralocorticoid excess: Genotype is correlated with biochemical phenotype [J].

Mune, T ;

White, PC .

HYPERTENSION, 1996, 27 (06) :1193-1199

[3] Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man [J].

Palermo, M ;

Shackleton, CHL ;

Mantero, F ;

Stewart, PM .

CLINICAL ENDOCRINOLOGY, 1996, 45 (05) :605-611

[4] A genetic defect resulting in mild low-renin hypertension [J].

Wilson, RC ;

Dave-Sharma, S ;

Wei, JQ ;

Obeyesekere, VR ;

Li, K ;

Ferrari, P ;

Krozowski, ZS ;

Shackleton, CHL ;

Bradlow, L ;

Wiens, T ;

New, MI .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :10200-10205

← 1 →